Swisscanto Private Equity
Europe, Zurich, Switzerland, Zürich
Description
We invest in growth companies in the "late-stage venture/growth capital" phase, focussed on the technology and healthtech sectors.
Investor Profile
Swisscanto Private Equity has made 28 investments, with 2 in the past 12 months and 43% as lead.
Stage Focus
- Series B (57%)
- Series C (14%)
- Series Unknown (14%)
- Convertible Note (4%)
- Series A (4%)
- Series E (4%)
- Secondary Market (4%)
Country Focus
- Switzerland (71%)
- Denmark (11%)
- Germany (11%)
- Belgium (4%)
- Finland (4%)
Industry Focus
- Biotechnology
- Software
- Robotics
- Health Care
- Manufacturing
- Enterprise Software
- Mobile
- Saas
- Unified Communications
- Health Diagnostics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
